Furthermore, pharmacological PKM2 agonists, which limit PKM2 nuclear translocation, effectively ameliorate MCD-induced NASH in mice by re-educating macrophages from M1 to M2 polarization [95]. This evidence concerns the gene PKM and metabolic dysfunction-associated steatohepatitis.